Not finding it? Sign in to also search OpenAlex live.
-
Cell-penetrating peptide-conjugated copper complexes for redox-mediated anticancer therapy2022 Frontiers in Pharmacology article Medicine Metal complexes synthesis and properties Open access
Quim Peña, Sergi Rodríguez-Calado, Ariane Jalila Simaan, Mercè Capdevila, Pau Bayón, Òscar Palacios, +2 more
17citations -
Debio 0123-101: A phase 1 trial of Debio 0123 in combination with carboplatin in advanced solid tumors—Safety, pharmacokinetic, and preliminary antitumor activity data.
Hans A. J. Gelderblom, Mathilde Jalving, Ingrid M.E. Desar, Omar Saavedra, Jourik A. Gietema, Stefan G. van Ravensteijn, +7 more
16citations -
Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity2020 Cancer Cell article Medicine Monoclonal and Polyclonal Antibodies Research Open access cited by 11 patents
Xiaojie Yu, H.T. Claude Chan, Hayden Fisher, Christine A. Penfold, Jinny Kim, Tatyana Inzhelevskaya, +10 more
77citations -
A first-in-human, phase 1 dose escalation and expansion study evaluating the safety, tolerability, and anti-tumor activity of [225Ac]Ac-FL-020, an anti-PSMA radioconjugate, in patients with metastatic castration-resistant prostate cancer (mCRPC).2025 Journal of Clinical Oncology conference-abstract Medicine Radiopharmaceutical Chemistry and Applications
Andrei H. Iagaru, GIUSEPPE T. CARDACI, Aaron Richard Hansen, Jeffrey Y.C. Wong, Carlos Artigas, Karolien E. Goffin, +7 more
0citations -
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study
Tim H. Brümmendorf, Patrick G. Medd, Raphael Koch, Stephan Stilgenbauer, Shringi Sharma, Yun He, +4 more
8citations -
Multimodal analysis unveils tumor microenvironment heterogeneity linked to immune activity and evasion2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access
Óscar Lapuente-Santana, Gregor Sturm, Markus Außerhofer, Constantin Zackl, Maria Zopoglou, Nicholas McGranahan, +5 more
0citations -
Synthesis, characterization and cytotoxicity studies of Co(III)-flavonolato complexes2021 Journal of Inorganic Biochemistry article Medicine Metal complexes synthesis and properties Open access
Máté Kozsup, Xue‐Quan Zhou, Etelka Farkas, Attila Csaba Bényei, Sylvestre A. Bonnet, Tamás Patonay, +2 more
26citations -
Exploring the effects of taurolidine on tumor weight and microvessel density in a murine model of osteosarcoma2024 Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics article Medicine Sarcoma Diagnosis and Treatment Open access
Lisanne K. A. Neijenhuis, Sonia A M Ferkel, Samuel J. S. Rubin, Stephan Rogalla
2citations -
Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors2025 Cancer Research Communications article Medicine Lung Cancer Treatments and Mutations Open access cited by 1 patent
Kristoffer Staal Rohrberg, Juanita Suzanne Lopez, Mohammed M. Milhem, Christian U. Blank, Irene L. M. Reijers, Fiona C. Thistlethwaite, +34 more
4citations -
Phase 1b study of AMG 757, a half-life extended bispecific T-cell engager (HLE BiTEimmune-oncology therapy) targeting DLL3, in de novo or treatment emergent neuroendocrine prostate cancer (NEPC).2021 Journal of Clinical Oncology conference-abstract Medicine Prostate Cancer Treatment and Research
Rahul Raj Aggarwal, Ana Maria Aparicio, Axel Heidenreich, Shahneen Kaur Sandhu, Yiran Zhang, Mark Salvati, +1 more
14citations -
A first-in-human study of DYP688, an antibody drug conjugate delivering a direct Gq/11 inhibitor, in patients with metastatic uveal melanoma (MUM) and other GNAQ/11 mutant melanomas.2025 Journal of Clinical Oncology conference-abstract Medicine Ocular Oncology and Treatments Open access
Matteo Salvatore Carlino, Reinhard Dummer, Tanja Gromke, Jessica Cecile Hassel, Ellen Kapiteijn, Damien Kee, +12 more
6citations